EUVIMEDSkopri EUVIMED
Video/AudioFallbericht

Recognizing and Treating Catatonia in Kleefstra Syndrome

Miriam Vail, Jonathan Newgren, Isabelle Bindseil, Danielle Stutzman, Elizabeth Margolis

Journal of Visualized Experiments · 2025

DOI: 10.3791/68333 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Miriam Vail and 4 co-authors. Institution: Department of Child and Adolescent Psychiatry, University of Colorado; miriam.vail@cuanschutz.edu. Major MEDLINE topics: Catatonia, Intellectual Disability, Craniofacial Abnormalities, Heart Defects, Congenital. 14 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Kleefstra syndrome is a rare genetic disorder (less than 1 in 1,000,000) associated with a mutation of the euchromatic histone lysine methyltransferase 1 gene of the ninth chromosome. This gene controls the production of the enzyme, histone methyltransferase 1, which has widespread impacts on the body's ability to function. There are numerous physiologic impacts of the genetic abnormalities associated with Kleefstra syndrome, including psychiatric and behavioral comorbidities. One of these comorbidities is Catatonia. Catatonia is a neuropsychiatric syndrome that is associated with psychomotor disturbances, with individuals either appearing to be hypokinetic or, less commonly, hyperkinetic. It is defined by a compilation of symptoms that range from changes in communication, movements, and behaviors. Though case reports in the literature are nonexistent, Catatonia is known to be associated with Kleefstra syndrome. Furthermore, the successful treatment of Catatonia associated with Kleefstra has not yet been reported. This case describes a 17-year-old male with a history of Kleefstra syndrome and Catatonia who was successfully treated with scheduled Lorazepam. Discussion of such a case in the literature is important to help other providers appropriately diagnose and treat this often overlooked psychiatric condition in patients with complex genetic syndromes.

Subjects

MeSH terms (MEDLINE)

CatatoniaIntellectual DisabilityCraniofacial AbnormalitiesHeart Defects, CongenitalHumansMaleAdolescentChromosome DeletionLorazepamChromosomes, Human, Pair 9

Substances

Lorazepam

Authors and institutions

  • Department of Child and Adolescent Psychiatry, University of Colorado; miriam.vail@cuanschutz.edu.
  • Department of Child and Adolescent Psychiatry, University of Colorado.
  • Department of Pharmacy, Children's Hospital Colorado.
  • Department of Child and Adolescent Psychiatry, University of Colorado; Department of Pharmacy, Children's Hospital Colorado; Pediatric Mental Health Institute, Children's Hospital Colorado.
  • Department of Child and Adolescent Psychiatry, University of Colorado; Pediatric Mental Health Institute, Children's Hospital Colorado; Elizabeth.Margolis@childrenscolorado.org.

Cite

APA

Vail, M., Newgren, J., Bindseil, I., Stutzman, D., & Margolis, E. (2025). Recognizing and Treating Catatonia in Kleefstra Syndrome. Journal of Visualized Experiments. https://doi.org/10.3791/68333

Vancouver

Vail M, Newgren J, Bindseil I, Stutzman D, Margolis E. Recognizing and Treating Catatonia in Kleefstra Syndrome. Journal of Visualized Experiments. 2025. doi:10.3791/68333

BibTeX
@article{Vail2025,
  author = {Vail, Miriam and Newgren, Jonathan and Bindseil, Isabelle and Stutzman, Danielle and Margolis, Elizabeth},
  title = {Recognizing and Treating Catatonia in Kleefstra Syndrome},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/68333}
}
Start for free →